
|
Critisense is an Israeli medical device company that is developing an innovative system for monitoring the metabolic state of patients in critical condition.

EarlySense is a medical device company that has developed a system, based on advanced sensing and signal processing technologies, to take patient compliance out of the chronic care equation.

Navotek is an Israeli medical device company developing a system that will enable the precice location of tumors.

Arbel Medical is an Israeli medical device company that develops innovative, minimally invasive cryotherapy products focused on the women's health market, with an initial application for benign breast tumors.
|